Copyright
©The Author(s) 2004.
World J Gastroenterol. Mar 1, 2004; 10(5): 689-693
Published online Mar 1, 2004. doi: 10.3748/wjg.v10.i5.689
Published online Mar 1, 2004. doi: 10.3748/wjg.v10.i5.689
Table 1 Serum levels of TNFα, ET-1 and NO and hepatic NOS activities in PVL and cPHT rats
Groups | TNFα | ET-1 | NO | NOS |
(pg/min) | (pg/min) | (µmol/L) | (u/mg·prot) | |
Control | 48.67 ± 32.79 | 8.72 ± 0.79 | 113 ± 15 | 0.9 ± 0.03 |
aPHT | ||||
PVL0.5 h | 50 ± 15 | 13.4 ± 2.6 | 128.64 ± 18.29 | 0.86 ± 0.14 |
PVL24 h | 328 ± 100ac | 12.8 ± 5.7 | 169.40 ± 21.07ac | 1.45 ± 0.17ac |
PVL48 h | 428 ± 69a | 13.5 ± 2.6 | 223.71 ± 35.44a | 1.7 ± 0.12a |
PVL72 h | 416 ± 48a | 13.1 ± 3.2 | 215.49 ± 12.75a | 1.67 ± 0.16a |
PVL120 h | 425 ± 49a | 13.4 ± 3.5 | 225.36 ± 18.66a | 1.7 ± 0.12a |
cPHT | 477.67 ± 83.81ae | 14.33 ± 4.42 | 278.41 ± 20.11ae | 1.81 ± 0.06a |
Table 2 Effects of anti-rat TNFa and L-NMMA on levels of TNFa, ET-1 and hepatic NO and NOS activity in PVL and cPHT rats
Groups | TNFα (pg/mL) | ET-1 (pg/mL) | NO (µmol/L) | NOS (u/mg·prot) |
Control | 48.67 ± 32.29 | 8.72 ± 0.79 | 113 ± 15 | 0.9 ± 0.03 |
cPHT | 477.67 ± 83.8ac | 14.33 ± 4.42 | 278.41 ± 20.11ac | 1.81 ± 0.06ac |
cPHT+anti-rat TNFα | 15.17 ± 18.79a | 14.33 ± 4.42 | 190.61 ± 10.9a | 1.39 ± 0.04a |
cPHT+L-NMMA | - | - | 119.18 ± 11.51e | 4.92 ± 0.03e |
PVL72 h | 416 ± 48ag | 13.1 ± 3.2 | 215.49 ± 12.75ag | 1.67 ± 0.16ag |
PVL72 h+anti-rat TNFα | 14 ± 14a | 13.5 ± 2.6 | 178.59 ± 14.61a | 1.34 ± 0.09a |
PVL72 h+L-NMMA | - | - | 104.61 ± 18i | 0.95 ± 0.08i |
Table 3 Effects of anti-rat TNFα and L- NMMA on homodynamic variables
Groups | SV | CO | PP | SMAflow | IAflow | VRSMA | VRIA |
(mL/s) | (L/min) | (kPa) | (mL/min) | (mL/min) | (kPa/.L·min) | (kPa/.L·min) | |
Control | 0.162 ± 0.04 | 0.05 ± 0.017 | 0.91 ± 0.16 | 8.42 ± 1.16 | 10 ± 0.89 | 15.57 ± 2.74 | 13.58 ± 2.19 |
cPHT | 0.59 ± 0.06ac | 0.159 ± 0.031ac | 2.26 ± 0.34ac | 27 ± 3.19ac | 27.33 ± 1.21ac | 4.07 ± 0.43ac | 4.44 ± 0.51ac |
CPHT+anti-rat TNFα | 0.39 ± 0.08a | 0.138 ± 0.029a | 1.53 ± 0.13a | 20.75 ± 1.92a | 24.15 ± 1.67a | 5.56 ± 0.59a | 5.21 ± 0.51a |
cPHT+L-NMMA | 0.32 ± 0.02a | 0.076 ± 0.005e | 1.12 ± 0.08e | 12.75 ± 0.82ae | 16.08 ± 0.74ae | 10.13 ± 0.26ae | 8.84 ± 0.66ae |
PVL72 h | 0.42 ± 0.03ag | 0.143 ± 0.029ag | 2.38 ± 0.05ag | 23.27 ± 1..52ag | 25.43 ± 1.44ag | 4.44 ± 0.28ag | 4.54 ± 0.32ag |
PVL72 h+anti-rat TNFα | 0.33 ± 0.02a | 0.127 ± 0.008a | 1.68 ± 0.12a | 19.3 ± 1.1a | 20.7 ± 2a | 5.9 ± 0.1a | 6.0 ± 0.5a |
PVL72 h+L-NMMA | 0.24 ± 0.04i | 0.072 ± 0.013i | 0.85 ± 0.15i | 9.82 ± 0.96i | 10.77 ± 1.11i | 12.58 ± 0.93i | 12.42 ± 0.99i |
- Citation: Wang JJ, Gao GW, Gao RZ, Liu CA, Ding X, Yao ZX. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension. World J Gastroenterol 2004; 10(5): 689-693
- URL: https://www.wjgnet.com/1007-9327/full/v10/i5/689.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i5.689